New Factor 8 Protocol Being Tested

Saudi Arabia has new intravenous (IV) medication preparation standards designed to reduce the risk of contamination. JHAH has proactively positioned itself to safely exceed them. “When the guidelines were released in the U.S., which organizations were not required to meet, we adopted them as our benchmark and formed a multidisciplinary team to explore,” said Fuad Ghamdi, Pharmacy Department director. “As a result, the particle counts in the JHAH IV prep room outperform the new standard, which helps protect our patients by averting the highest risk potential errors caused by particle contamination.”